These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2834049)

  • 21. Prostatic acid phosphatase in the serially transplantable human prostatic tumor lines PC-82 and PC-EW.
    Csapo Z; Brand K; Schrott KM; Schwindl B
    Urol Res; 1990; 18(2):137-42. PubMed ID: 2339482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of disease flare with diethylstilbestrol diphosphate and chlormadinone acetate administration for two weeks prior to slow-releasing leuprolide acetate in prostatic cancer patients.
    Ohuchi H; Noguchi K; Kinoshita Y; Hosaka M; Kawasaki C; Miura T; Kondo I; Harada M
    Hinyokika Kiyo; 2000 Aug; 46(8):531-6. PubMed ID: 11019371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunoassay of diethylstilbestrol in plasma of patients with prostatic carcinoma.
    Usui T; Nakamura K; Osumi T; Ishibe T; Kitano T; Kambegawa A; Miyachi Y
    Arch Androl; 1984; 12(2-3):243-9. PubMed ID: 6508431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression of prostatic cancer metastasis by high doses of diethylstilbestrol diphosphate.
    Susan LP; Roth RB; Adkins WC
    Urology; 1976 Jun; 7(6):598-601. PubMed ID: 936380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
    Oh WK; Kantoff PW; Weinberg V; Jones G; Rini BI; Derynck MK; Bok R; Smith MR; Bubley GJ; Rosen RT; DiPaola RS; Small EJ
    J Clin Oncol; 2004 Sep; 22(18):3705-12. PubMed ID: 15289492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of prostate cancer with a large abdominal mass effectively treated with a high dose of diethylstilbestrol-diphosphate.
    Wakisaka M; Takagishi H
    Hinyokika Kiyo; 1993 Sep; 39(9):849-51. PubMed ID: 8213382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Divergent biological effects of estradiol and diethylstilbestrol in the prostate cancer cell line MOP.
    Kalach JJ; Joly-Pharaboz MO; Chantepie J; Nicolas B; Descotes F; Mauduit C; Benahmed M; André J
    J Steroid Biochem Mol Biol; 2005 Jul; 96(2):119-29. PubMed ID: 15950459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells.
    Lin MF; DaVolio J; Garcia-Arenas R
    Cancer Res; 1992 Sep; 52(17):4600-7. PubMed ID: 1380886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells.
    Morris GZ; Williams RL; Elliott MS; Beebe SJ
    Prostate; 2002 Sep; 52(4):319-29. PubMed ID: 12210493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposome-entrapped diethylstilbestrol effect on prostate gland and plasma testosterone levels in rats.
    Jackson AJ; Franklin RB
    Endocrinology; 1984 Aug; 115(2):538-43. PubMed ID: 6745169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth inhibition by diethylstilbestrol and relapse of the Noble rat prostatic tumor.
    Wakisaka M; Drury RE; Kadohama N
    Hinyokika Kiyo; 1988 Jan; 34(1):107-15. PubMed ID: 3376790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the expression of prostatic acid phosphatase in LNCaP human prostate carcinoma cells.
    Lin MF; Garcia-Arenas R; Kawachi M; Lin FF
    Cell Mol Biol Res; 1993; 39(8):739-50. PubMed ID: 7951413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diethylstilbestrol di-trimethylacetate (DSTMA). A long-acting estrogen.
    Noland JL; Amin M
    Invest Urol; 1980 May; 17(6):506-9. PubMed ID: 7372439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the mammary tumor-inhibiting effects of diethylstilbestrol and its mono- and diphosphate.
    Schneider MR; von Angerer E; Prekajac J; Brade WP
    J Cancer Res Clin Oncol; 1986; 111(2):110-4. PubMed ID: 3754557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basal and estrogen-stimulated hormone receptor profiles in four R3327 rat prostatic carcinoma sublines in relation to histopathology and androgen sensitivity.
    Mobbs BG; Johnson IE
    Cancer Res; 1988 Jun; 48(11):3077-83. PubMed ID: 3259159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of diethylstilbestrol induced cytotoxicity by bcl-2 antisense oligodeoxynucleotides and a glutathione depletor for prostate cancer.
    Kikuchi E; Nakashima J; Horiguchi Y; Oya M; Ohigashi T; Murai M
    J Urol; 2003 Feb; 169(2):730-4. PubMed ID: 12544353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability, distribution and pharmacokinetics of diethylstilbestrol converted from diethylstilbestrol diphosphate in patients with prostatic cancer.
    Nakamura K
    Hiroshima J Med Sci; 1986 Dec; 35(4):325-38. PubMed ID: 3570844
    [No Abstract]   [Full Text] [Related]  

  • 38. [High-dose intravenous diethylstilbestrol diphosphate therapy for hormone refractory prostate cancer].
    Honda M; Umeda H; Yoshida K
    Nihon Rinsho; 1998 Aug; 56(8):2145-9. PubMed ID: 9750524
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of intravenous stilbestrol diphosphate in patients with prostatic carcinoma refractory to conventional hormonal manipulation.
    Ferro MA
    Urol Clin North Am; 1991 Feb; 18(1):139-43. PubMed ID: 1992567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dependence on exogenous metabolic activation for induction of unscheduled DNA synthesis in Syrian hamster embryo cells by diethylstilbestrol and related compounds.
    Tsutsui T; Degen GH; Schiffmann D; Wong A; Maizumi H; McLachlan JA; Barrett JC
    Cancer Res; 1984 Jan; 44(1):184-9. PubMed ID: 6317168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.